Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection.
Skrek S, Di Lernia V, Beauchet A, Bursztejn AC, Belloni Fortina A, Lesiak A, Thomas J, Brzezinski P, Topkarci Z, Murashkin N, Torres T, Epishev R, Chiriac A, McPherson T, Akinde M, Maruani A, Luna PC, Vidaurri de la Cruz H, Mallet S, Leducq S, Sergeant M, Zitouni J, Mahil SK, Smith CH, Flohr C, Bachelez H, Mahé E; Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology, and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.). Skrek S, et al. Among authors: bachelez h. J Eur Acad Dermatol Venereol. 2023 Oct;37(10):e1192-e1195. doi: 10.1111/jdv.19261. Epub 2023 Jun 27. J Eur Acad Dermatol Venereol. 2023. PMID: 37326146 No abstract available.
Pustular Psoriasis: The Dawn of a New Era.
Bachelez H. Bachelez H. Acta Derm Venereol. 2020 Jan 30;100(3):adv00034. doi: 10.2340/00015555-3388. Acta Derm Venereol. 2020. PMID: 31971600 Free PMC article. Review.
Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment.
Abboud E, Chrayteh D, Boussetta N, Dalle H, Malerba M, Wu TD, Le Gall M, Reelfs O, Pourzand C, Mellett M, Assan F, Bachelez H, Poupon J, Aractingi S, Vaulont S, Sohier P, Oules B, Karim Z, Peyssonnaux C. Abboud E, et al. Among authors: bachelez h. Nat Commun. 2024 Aug 7;15(1):6718. doi: 10.1038/s41467-024-50993-8. Nat Commun. 2024. PMID: 39112467 Free PMC article.
Spesolimab Reduces Inflammation in Generalized Pustular Psoriasis: Molecular Characterization of Flare Treatment in EFFISAYIL 1.
Farag A, Visvanathan S, Bachelez H, Morita A, Lebwohl MG, Barker JN, Choon SE, Burden AD, Tsai TF, Leparc G, Delic D, Lang B, Thoma C, Krueger JG. Farag A, et al. Among authors: bachelez h. J Invest Dermatol. 2024 Jul 14:S0022-202X(24)01888-8. doi: 10.1016/j.jid.2024.05.034. Online ahead of print. J Invest Dermatol. 2024. PMID: 39004117
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Choon SE, van de Kerkhof P, Gudjonsson JE, de la Cruz C, Barker J, Morita A, Romiti R, Affandi AM, Asawanonda P, Burden AD, Gonzalez C, Marrakchi S, Mowla MR, Okubo Y, Oon HH, Terui T, Tsai TF, Callis-Duffin K, Fujita H, Jo SJ, Merola J, Mrowietz U, Puig L, Thaçi D, Velásquez M, Augustin M, El Sayed M, Navarini AA, Pink A, Prinz J, Turki H, Magalhães R, Capon F, Bachelez H; IPC Pustular Psoriasis Working Group. Choon SE, et al. Among authors: bachelez h. JAMA Dermatol. 2024 Jul 1;160(7):758-768. doi: 10.1001/jamadermatol.2024.0915. JAMA Dermatol. 2024. PMID: 38691347
Tofacitinib efficacy, patient-reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies.
Bachelez H, Griffiths CEM, Papp KA, Hall S, Merola JF, Feldman SR, Khraishi M, Tan H, Fallon L, Cappelleri JC, Bushmakin AG, Young P. Bachelez H, et al. J Eur Acad Dermatol Venereol. 2024 Jul;38(7):e557-e561. doi: 10.1111/jdv.19701. Epub 2024 Jan 11. J Eur Acad Dermatol Venereol. 2024. PMID: 38213065 No abstract available.
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitless trial).
Strober B, Bachelez H, Crowley J, Elewski BE, Gooderham M, Menter A, Strohal R, Chen MM, Wu T, Zhan T, Photowala H, Armstrong A. Strober B, et al. Among authors: bachelez h. J Eur Acad Dermatol Venereol. 2024 May;38(5):864-872. doi: 10.1111/jdv.19748. Epub 2024 Jan 5. J Eur Acad Dermatol Venereol. 2024. PMID: 38179809 Clinical Trial.
292 results